A promising new HIV vaccine was set to start trials. Then came Trump's latest cuts
NPRTuesday, June 10, 2025 at 2:16:46 PM
Just as scientists were gearing up for human trials of a potentially groundbreaking HIV vaccine, the Trump administration pulled the plug on their NIH funding. The research team learned on May 30 that their program will lose financial support next year, throwing a wrench into years of promising medical progress.
Editor’s Note: This isn’t just another budget cut—it’s a setback for a vaccine that could have changed millions of lives. HIV still affects over 38 million people globally, and while treatments exist, prevention remains the holy grail. Slashing funding now doesn’t just stall science; it risks losing momentum on what could have been a major breakthrough. For communities disproportionately impacted by HIV, this move feels especially harsh.
— Curated via WP Now’s
